Natco Pharma Shares Drop 15 Following Weak Q4 Results Net Profit Falls 34 YoY ARTNA Q3 2025 Earnings Modest EPS Beat Amid Quiet Trading Consumer Credit Growth Accelerates in December Implications for Spending and Economic Outlook